UC San Diego researchers developed first-of-their-kind lung organoids that include all cell types that make up the organ, allowing for “Phase 0” testing of new treatments for respiratory infections such as COVID-19.
News
Artificial Intelligence Could Be New Blueprint for Precision Drug Discovery
Researchers at University of California San Diego School of Medicine describe a new approach that uses machine learning to hunt for disease targets and then predicts whether a drug is likely to receive FDA approval. Click here to view original post… […]
News
Two UC San Diego Scientists Elected to National Academy of Medicine
Leaders in cell biology and anti-malarial drug development respectively, JoAnn Trejo and Elizabeth Winzeler were recognized by their peers with one of the highest honors in health and medicine.
[…]
News
UC San Diego Named Inaugural Partner in Statewide College Corps Initiative
This spring, more than 100 undergraduate students will have the opportunity to apply to be part of a new statewide program designed to help address some of California’s most urgent challenges. UC San Diego was s… […]
